Showing results (101-110 of 438) with videos related to
Sort By:
Pageof 44
Journal for Immunotherapy of Cancer|November 18, 2025
Prognosis and treatment response stratification according to loss of proofreading (LOP) POLE variantsGiulia Maddalena, Fadl A Zeineddine, Saikat Chowdhury, et al.Journal of Clinical Pathology|February 11, 2022
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practicePaola Parente, Umberto Malapelle, Valentina Angerilli, et al.Cancers|March 10, 2022
HER2-CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric AdenocarcinomaValli De Re, Lara Alessandrini, Giulia Brisotto, et al.The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2025
Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancersMohamed E Salem, Alberto Puccini, Elizabeth Mauer, et al.Current Oncology (Toronto, Ont.)|June 27, 2023
Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?Ottavia De Simoni, Luca Dal Santo, Marco Scarpa, et al.Future Oncology (London, England)|September 13, 2023
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancerThierry André, Filippo Pietrantonio, Antonio Avallone, et al.Archives of Medical Research|September 15, 2006
5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term resultsSalvatore Pucciarelli, Emanuele Urso, Gian Luca DeSalvo, et al.Journal of Experimental & Clinical Cancer Research : CR|December 24, 2015
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published dataLorenzo Fornaro, Caterina Vivaldi, Stefano Cereda, et al.International Journal of Molecular Sciences|September 9, 2016
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer PatientsEva Dreussi, Erika Cecchin, Jerry Polesel, et al.Pageof 44